Single-cell Analysis Market: Overview

The global single-cell analysis market is emerging as a space that has whetted investors’ interest. This is attributable to the market having surmounted numerous challenges associated with sample preparation and data analysis. Moreover, continuous and rapid developments in the field of single-cell analysis research have led to the emergence of new technologies, application areas, and consumables.

The single-cell analysis market began to take shape after evidence emerged that even within small cell population, heterogeneity did exist. Prior to this, the general assumption was that cell populations were usually homogeneous. Further research in the field of single-cell analysis has today enabled biologists to learn more about gene expression profiles in individual cells. It has also helped avoid errors that would otherwise stem from life sciences experts taking averages of an entire group of cells.

Gene expression measurements based on the assumption that cell populations are homogenous can be misleading and often leave out seemingly minor but important changes in single cells. Because these individual cells can sometimes differ vastly in terms of their protein levels, size, and expressed RNA transcripts, they could sometimes offer answers to breakthrough treatment in cancer research, immunology, stem cell biology, and more.

Download exclusive Sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10565

The report on the global single-cell analysis market briefly tracks the market’s growth from its early days to its current position. A detailed segmentation of the global single-cell analysis market has been carried out to include the various tools and consumables, types of cells, end users, and regional markets. The report provides forecasts and projections for the overall market as well as for all of its leading segments. This will help companies in the global single-cell analysis market to base their growth decisions on verifiable insights.

Single-cell Analysis Market: Trends and Opportunities

The global single-cell analysis market is expected to register a high double-digit compounded annual growth rate (CAGR) through the review period of the report. With government agencies in several developed markets taking an active interest in funding initiatives related to single-cell analysis research, the market is expected to develop a strong foundation in traditional markets such as North America and Europe. There are new opportunities emerging in the biopharmaceuticals and biologics sector, where the use of single-cell analysis can prove to be a game-changer.

Companies in the global single-cell analysis market are thus recommended to focus on these emerging areas to harness the maximum revenue potential of various single-cell analysis technologies and consumables.

The growth of the single-cell analysis market in major developing countries will not be entirely disappointing over the next few years. There exist numerous opportunities in China, Japan, Australia, and India that companies will benefit from. However, even as companies do so, it is expected that the high cost of single-cell analysis instruments could dampen their efforts to some degree.

Given that the market for single-cell analysis has only recently emerged, much of the demand-based revenue in the market will come from research initiatives and academic entities.

Single-cell Analysis Market: Competitive Landscape

The mounting interest in single-cell analysis has thus led to several existing companies in the global life sciences sector to enter the single-cell analysis consumables and technologies market as well. The single-cell tools available on the market today help life sciences researchers and biologists wade through numerous workflows in all kinds of research, be it translational, clinical, or basic.

Companies that have gained an early foothold in the global single-cell analysis market include: Beckman Coulter, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Fluidigm Corporation, and Illumina, Inc.